135 related articles for article (PubMed ID: 31073181)
1. Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.
Kumar V; LaJevic M; Pandrala M; Jacobo SA; Malhotra SV; Zabel BA
Sci Rep; 2019 May; 9(1):7178. PubMed ID: 31073181
[TBL] [Abstract][Full Text] [Related]
2. A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease.
Graham KL; Zhang JV; Lewén S; Burke TM; Dang T; Zoudilova M; Sobel RA; Butcher EC; Zabel BA
PLoS One; 2014; 9(12):e112925. PubMed ID: 25437209
[TBL] [Abstract][Full Text] [Related]
3. CMKLR1 deficiency attenuates androgen-induced lipid accumulation in mice.
Huang B; Zhao H; Huang C; Wu L; Xiang L; Chen J; Wang B; Xiao T; Li M; Ren L; Niu J; Zhang JV
Am J Physiol Endocrinol Metab; 2020 Mar; 318(3):E371-E380. PubMed ID: 31910029
[TBL] [Abstract][Full Text] [Related]
4. CMKLR1 Antagonist Alpha-NETA Protects against Diabetic Nephropathy in Mice.
Peng Z; Wang X; Zhu Q; Wang H; Li B; Pang X; Han J
Kidney Blood Press Res; 2023; 48(1):405-413. PubMed ID: 37231814
[TBL] [Abstract][Full Text] [Related]
5. α-NETA down-regulates CMKLR1 mRNA expression in ileum and prevents body weight gains collaborating with ERK inhibitor PD98059 in turn to alleviate hepatic steatosis in HFD-induced obese mice but no impact on ileal mucosal integrity and steatohepatitis progression.
Zheng C; Zheng Y; Chen X; Zhong X; Zheng X; Yang S; Zheng Z
BMC Endocr Disord; 2023 Jan; 23(1):9. PubMed ID: 36624417
[TBL] [Abstract][Full Text] [Related]
6. Alpha-NETA, as a CMKLR1 Small Molecule Antagonist, Protects against Renal Ischemia Reperfusion Injury in Mice.
Peng X; Wang W; Wang W; Qi J
Protein Pept Lett; 2022; 29(11):962-970. PubMed ID: 35996267
[TBL] [Abstract][Full Text] [Related]
7. Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression.
Yu M; Yang Y; Zhao H; Li M; Chen J; Wang B; Xiao T; Huang C; Zhao H; Zhou W; Zhang JV
Front Pharmacol; 2022; 13():985618. PubMed ID: 36523492
[TBL] [Abstract][Full Text] [Related]
8. Relationships between chemical structure and inhibition of choline acetyltransferase by 2-(alpha-naphthoyl)ethyltrimethylammonium and related compounds.
Sastry BV; Jaiswal N; Janson V; Day PS; Naukam RJ
Pharmacol Res Commun; 1988 Sep; 20(9):751-71. PubMed ID: 3174803
[TBL] [Abstract][Full Text] [Related]
9. 2-(alpha-Naphthoyl)ethyltrimethylammonium iodide and its beta-isomer: new selective, stable and fluorescent inhibitors of choline acetyltransferase.
Sastry BV; Jaiswal N; Owens LK; Janson VE; Moore RD
J Pharmacol Exp Ther; 1988 Apr; 245(1):72-80. PubMed ID: 3361452
[TBL] [Abstract][Full Text] [Related]
10. Effect of alpha-NETA on auditory event related potentials in sensory gating study paradigm in mice.
Aleksandrov AA; Dmitrieva ES; Volnova AB; Knyazeva VM; Polyakova NV; Ptukha MA; Gainetdinov RR
Neurosci Lett; 2019 Nov; 712():134470. PubMed ID: 31476355
[TBL] [Abstract][Full Text] [Related]
11. Role of chemerin/CMKLR1 in the maintenance of early pregnancy.
Yang X; Yao J; Wei Q; Ye J; Yin X; Quan X; Lan Y; Xing H
Front Med; 2018 Oct; 12(5):525-532. PubMed ID: 29556954
[TBL] [Abstract][Full Text] [Related]
12. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
[TBL] [Abstract][Full Text] [Related]
13. Chemerin/CMKLR1 pathway exacerbates cisplatin-induced spiral ganglion neuron injury.
Tian J; Mu Y; Ma L
Toxicol Res; 2024 Jan; 40(1):73-81. PubMed ID: 38223664
[TBL] [Abstract][Full Text] [Related]
14. α-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway.
Qiao L; Wu X; Zhang J; Liu L; Sui X; Zhang R; Liu W; Shen F; Sun Y; Xi X
FASEB J; 2019 Nov; 33(11):12760-12767. PubMed ID: 31480859
[TBL] [Abstract][Full Text] [Related]
15. Identification of TAAR5 Agonist Activity of Alpha-NETA and Its Effect on Mismatch Negativity Amplitude in Awake Rats.
Aleksandrov AA; Knyazeva VM; Volnova AB; Dmitrieva ES; Korenkova O; Espinoza S; Gerasimov A; Gainetdinov RR
Neurotox Res; 2018 Oct; 34(3):442-451. PubMed ID: 29713997
[TBL] [Abstract][Full Text] [Related]
16. Putative Trace-Amine Associated Receptor 5 (TAAR5) Agonist α-NETA Increases Electrocorticogram Gamma-Rhythm in Freely Moving Rats.
Belov DR; Efimova EV; Fesenko ZS; Antonova KA; Kolodyazhny SF; Lakstygal AM; Gainetdinov RR
Cell Mol Neurobiol; 2020 Mar; 40(2):203-213. PubMed ID: 31385135
[TBL] [Abstract][Full Text] [Related]
17. The TAAR5 agonist α-NETA causes dyskinesia in mice.
Aleksandrov AA; Polyakova NV; Vinogradova EP; Gainetdinov RR; Knyazeva VM
Neurosci Lett; 2019 Jun; 704():208-211. PubMed ID: 30986441
[TBL] [Abstract][Full Text] [Related]
18. Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
de Bruin NM; Schmitz K; Schiffmann S; Tafferner N; Schmidt M; Jordan H; Häußler A; Tegeder I; Geisslinger G; Parnham MJ
Behav Brain Res; 2016 Mar; 300():160-74. PubMed ID: 26692368
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability
Tümmler C; Snapkov I; Wickström M; Moens U; Ljungblad L; Maria Elfman LH; Winberg JO; Kogner P; Johnsen JI; Sveinbjørnsson B
Oncotarget; 2017 Nov; 8(56):95135-95151. PubMed ID: 29221117
[TBL] [Abstract][Full Text] [Related]
20. International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin
Kennedy AJ; Davenport AP
Pharmacol Rev; 2018 Jan; 70(1):174-196. PubMed ID: 29279348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
